Literature DB >> 2836623

Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.

R Hanecak1, P K Pattengale, H Fan.   

Abstract

Moloney murine leukemia virus (M-MuLV) is a replication-competent retrovirus which induces T-cell lymphoma in mice. The enhancer sequences present within the M-MuLV long terminal repeat (LTR) region of the proviral genome have been shown to influence the disease specificity of the virus strongly. We examined the contribution of the M-MuLV enhancers to the transcriptional activity and pathogenesis of M-MuLV by constructing LTRs containing heterologous enhancer elements. The simian virus 40 enhancer region (72- and 21-base-pair repeats) was inserted into the U3 region (at -150 base pairs) of the M-MuLV LTR (Mo + SV) and also into a deleted form of the LTR which lacks the M-MuLV enhancer sequences (delta Mo + SV). These chimeric LTRs were used to generate infectious M-MuLVs by transfection of corresponding proviral plasmids into mouse fibroblasts. The relative infectivities of Mo + SV and delta Mo + SV recombinant viruses as determined by rat XC cell plaque assay and reverse transcriptase assay were 60 to 70% of wild-type M-MuLV levels. To study the pathogenicity of these two recombinant viruses, we inoculated newborn NIH Swiss mice with either Mo + SV or delta Mo + SV M-MuLV. Both viruses induced disease more slowly than M-MuLV, which induces disease 2 to 4 months postinoculation. Mo + SV M-MuLV-inoculated animals became moribund at 3 to 13 months postinoculation, whereas delta Mo + SV M-MuLV-inoculated animals became moribund at 6 to 24 months postinoculation. The tumors induced by the two viruses were characterized histologically and molecularly. Mo + SV M-MuLV-induced tumors were primarily T-cell-derived lymphoblastic lymphomas containing extensive rearrangements of the T-cell receptor beta gene. In contrast, delta Mo + SV M-MuLV induced pre-B- and B-cell lymphoblastic lymphomas, B-cell-derived follicular-center cell lymphomas, and acute myeloid leukemia. The delta Mo + SV tumor DNAs from B-lineage tumors were typically rearranged at the immunoglobulin gene loci and contained germ line configurations of the T-cell receptor beta gene. Southern blot hybridization confirmed that the tumor DNAs contained the predicted Mo + SV M-MuLV or delta Mo + SV M-MuLV provirus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836623      PMCID: PMC253401          DOI: 10.1128/JVI.62.7.2427-2436.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences.

Authors:  J Banerji; S Rusconi; W Schaffner
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

2.  In vivo sequence requirements of the SV40 early promotor region.

Authors:  C Benoist; P Chambon
Journal:  Nature       Date:  1981-03-26       Impact factor: 49.962

3.  High efficiency transformation by direct microinjection of DNA into cultured mammalian cells.

Authors:  M R Capecchi
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

4.  Identification of D segments of immunoglobulin heavy-chain genes and their rearrangement in T lymphocytes.

Authors:  Y Kurosawa; H von Boehmer; W Haas; H Sakano; A Trauneker; S Tonegawa
Journal:  Nature       Date:  1981-04-16       Impact factor: 49.962

5.  A single-base change at a splice site in a beta 0-thalassemic gene causes abnormal RNA splicing.

Authors:  R Treisman; N J Proudfoot; M Shander; T Maniatis
Journal:  Cell       Date:  1982-07       Impact factor: 41.582

6.  Differences in human alpha-, beta- and delta-globin gene expression in monkey kidney cells.

Authors:  R K Humphries; T Ley; P Turner; A D Moulton; A W Nienhuis
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

7.  Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion.

Authors:  B G Neel; W S Hayward; H L Robinson; J Fang; S M Astrin
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

8.  Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis.

Authors:  B R Davis; B K Brightman; K G Chandy; H Fan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

9.  Low-multiplicity infection of Moloney murine leukemia virus in mouse cells: effect on number of viral DNA copies and virus production in producer cells.

Authors:  H Fan; R Jaenisch; P MacIsaac
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

10.  Simian virus 40 tandem repeated sequences as an element of the early promoter.

Authors:  P Gruss; R Dhar; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  13 in total

1.  Bone marrow depletion by 89Sr complements a preleukemic defect in a long terminal repeat variant of Moloney murine leukemia virus.

Authors:  Q X Li; H Fan
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Chromatin structure of recombinant Moloney murine leukemia virus proviral DNAs that contain tax-responsive sequences from human T-cell lymphotropic virus type II in the presence and absence of tax.

Authors:  H Kitado; H Fan
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

3.  A Moloney murine leukemia virus driven by the Jaagsiekte sheep retrovirus enhancers shows enhanced specificity for infectivity in lung epithelial cells.

Authors:  Kathleen McGee-Estrada; Massimo Palmarini; Claus Hallwirth; Hung Fan
Journal:  Virus Genes       Date:  2005-12       Impact factor: 2.332

4.  Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus.

Authors:  Véronique Voisin; Corinne Barat; Trang Hoang; Eric Rassart
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  Tandemization of a subregion of the enhancer sequences from SRS 19-6 murine leukemia virus associated with T-lymphoid but not other leukemias.

Authors:  S W Granger; L M Bundy; H Fan
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.

Authors:  B K Brightman; A Rein; D J Trepp; H Fan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

7.  Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.

Authors:  G Feuer; H Fan
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  The leukemogenic potential of an enhancer variant of Moloney murine leukemia virus varies with the route of inoculation.

Authors:  B Belli; H Fan
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

9.  Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.

Authors:  R Hanecak; P K Pattengale; H Fan
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

10.  Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.

Authors:  B Belli; A Patel; H Fan
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.